Preparation method of nifedipine tablet

A technology for nifedipine and dipine tablets, applied in the field of nifedipine tablets, can solve the problem that the particle size of nifedipine raw materials is not easy to control, and achieve the effects of improving the dissolution rate and ensuring product quality

Active Publication Date: 2015-06-03
常州康普药业有限公司
View PDF4 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The invention provides a method for preparing nifedipine tablets in order to overcome the deficiency that the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0015] Example 1

[0016] Per 10,000 pieces prepared

[0017] (1) The raw material nifedipine is ultra-finely pulverized with a jet mill to a particle size D50 of less than 1μm; other raw materials, magnesium stearate, microcrystalline cellulose, carboxymethyl starch and compressible starch, are processed by a universal high-speed pulverizer After crushing, use a vortex vibrating sieve to pass through a 120-mesh sieve; weigh the sieved raw and auxiliary materials, and take 500g of the raw and auxiliary materials nifedipine; take 20g of magnesium stearate, 200g of microcrystalline cellulose, and 750g of compressible starch. 570g of carboxymethyl starch is reserved.

[0018] (2) Preparation of adhesive: (per ten thousand pieces): 400ml of 1-3% hydroxypropyl methylcellulose 30% ethanol solution, 25ml of polysorbate-80, and 10g of sodium lauryl sulfate for adhesive Agent

[0019] (3) Transfer 500 g of nifedipine to the fluidized bed, and set the fan frequency to make the material in a g...

Example Embodiment

[0024] Example 2

[0025] Per 10,000 pieces prepared

[0026] (1) The raw material nifedipine is ultra-finely pulverized with a jet mill to a particle size D50 of less than 10μm; other raw materials, magnesium stearate, microcrystalline cellulose, carboxymethyl starch and compressible starch, are used in a universal high-speed pulverizer After crushing, use a vortex oscillating sieve to pass through a 120-mesh sieve; weigh the sieved raw and auxiliary materials, take 500g of the raw and auxiliary materials, nifedipine, and use a jet mill for ultrafine pulverization to a particle size of less than 1-10μm; take hard 20g magnesium fatty acid, 166.6g microcrystalline cellulose, 625.05g compressible starch, 528.35g carboxymethyl starch, spare;

[0027] (2) Preparation of adhesive: (per ten thousand pieces): 800ml of 1-3% hydroxypropyl methylcellulose 30% ethanol solution, add 45ml of polysorbate-80, add 30g of sodium lauryl sulfate for adhesive Agent

[0028] (3) Transfer 500 g of nifedi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a preparation method of a nifedipine tablet. The preparation method comprises the following steps: (1) using raw materials and auxiliary materials comprising nifedipine, carboxymethyl starch, PVP-K 30, lauryl sodium sulfate, microcrystalline cellulose, compressible starch, and ethanol; (2) using a jet mill to grind the nifedipine raw material in a superfine manner, controlling the particle size of the raw material to be 1-10 microns, and respectively crushing the microcrystalline cellulose, the carboxymethyl starch and the compressible starch; (3) adopting an ethanol solution of hydroxypropyl methyl cellulose as a binding agent, and adding PVP-K 30 and the lauryl sodium sulfate; (4) in a fluidized bed, spraying the binding agent onto the nifedipine raw material, and then enabling the raw material to pass through a sieve; (5) adding the raw material processed in the step (4), the carboxymethyl starch, the microcrystalline cellulose and the compressible starch into a granulator, dryly mixing, cutting, and spraying the binding agent to pelletize; (6) drying the prepared wet particles; (7) stabilizing the size of the particles; (8) mixing magnesium stearate with the stabilized particles, tableting, and coating.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to nifedipine tablets. Background technique [0002] Nifedipine is used for the prevention and treatment of angina pectoris caused by coronary heart disease, especially variant angina pectoris and angina pectoris caused by coronary artery spasm. It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris with obstructive airway diseases, and its curative effect is better than that of beta-receptor antagonists. It is also suitable for various types of hypertension, and has a good effect on intractable and severe hypertension. Because it can reduce afterload, it also has good curative effect on refractory congestive heart failure and is suitable for long-term use. [0003] First, the nifedipine raw material is pulverized, and then the processes such as granulation, tabletting and coating are carried out to prepare tablets. The above processes are mo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/28A61K9/20A61K31/4422A61P9/10
Inventor 王苏南汤金春
Owner 常州康普药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products